In Reply

Dtsch Arztebl Int. 2021 Apr 16;118(15):271-272. doi: 10.3238/arztebl.m2021.0109.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Endocrine Disruptors*
  • Humans
  • Hyperinsulinism*

Substances

  • Endocrine Disruptors